secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2023-01-05T23:59:59+00:00
Accession:  0001125345-23-000011
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics appoints Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
--------------------------------------------------------------------------------

- Appointments effective January 3, 2023; Liu joins Science & Tech Committee, Karson joins Audit Committee.
- Board expands to ten directors, nine of whom are independent.
- Dr. Liu is a gene therapy, vaccines, and immunotherapy expert; former exec at Merck and Chiron.
- Meenu Chhabra Karson is a biopharma executive; previously CEO of Proteostasis Therapeutics and led its IPO.
- Karson received an option to purchase 36,000 shares vesting monthly over 36 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000112534523000011/0001125345-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000112534523000011/mgnx-20230103.htm
  HTML page:      https://secwatch.observer/filing/0001125345-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer